Cheng et al. found that inhibiting myeloperoxidase (MPO) reduced inflammation-induced endothelial dysfunction in mouse models of vascular inflammation and atherosclerosis, highlighting its role in oxidative stress and inflammatory reactions [50]. Here, MPO is linked to endothelial dysfunction.